2 completed, 1 recruiting, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Recurrent Vaginal Carcinoma: new trials by email Literature Review of Recurrent Vaginal Carcinoma trials Research Report on Recurrent Vaginal Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers Quality-of-Life Assessment, Radiation Therapy, Talazoparib - Malignant Female Reproductive System Neoplasm, Recurrent Cervical Carcinoma | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 24 | 2019-09-26 | 2026-03-11 |
| DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457, Durvalumab - Human Papillomavirus-16 Positive, Human Papillomavirus-18 Positive | Phase 2 | Terminated | M.D. Anderson Cancer Center | 41 | 2018-11-14 | 2024-07-09 |
| Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers Durvalumab, Laboratory Biomarker Analysis, Stereotactic Radiosurgery - Advanced Cervical Adenocarcinoma, Advanced Vaginal Carcinoma | Phase 1 | Completed | M.D. Anderson Cancer Center | 20 | 2018-07-18 | 2023-09-13 |
| Collecting Tumor Samples From Patients With Gynecological Tumors Laboratory Biomarker Analysis - Borderline Ovarian Clear Cell Tumor, Borderline Ovarian Serous Tumor | Completed | Gynecologic Oncology Group | 275 | 1992-06-01 | 2016-10-28 |
Uterine Cervical Neoplasms (4) · Vaginal Neoplasms (4) · Vulvar Neoplasms (3) · Fallopian Tube Neoplasms (2) · Ovarian Neoplasms (2) · Anal Canal Carcinoma (1) · Anus Neoplasms (1) · Brenner Tumor (1) · Endometrial Neoplasms (1) · Gestational Trophoblastic Disease (1) · Melanoma (1) · Mesothelioma, Malignant (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Ovarian Germ Cell Cancer (1)
Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Genital Diseases (4) · Genital Diseases, Female (4) · Genital Neoplasms, Female (4) · Neoplasms by Site (4) · Urogenital Diseases (4) · Urogenital Neoplasms (4) · Uterine Cervical Diseases (4) · Uterine Diseases (4) · Uterine Neoplasms (4) · Vaginal Diseases (4) · Neoplasms (3) · Vulvar Diseases (3) · Adnexal Diseases (2)
Disulfides (2) · Immunoglobulin G (2) · durvalumab (2) · MEDI0457 (1) · Radiation (1) · Radiosurgery (1) · Radiotherapy (1) · VGX-3100 (1) · rocakinogene sifuplasmid (1) · talazoparib (1) · tremelimumab (1)
M.D. Anderson Cancer Center (3) · Gynecologic Oncology Group (1)
United States (4)
Lilie L Lin (2) · Michael Cibull (1) · Michael M Frumovitz (1)
U10CA180868 (1)